GUANGDONG HYBRIBIO revenue breakdown overview

GUANGDONG HYBRIBIO revenue for the last year amounted to 1.10 B CNY, the most of which — 837.56 M CNY — came from its highest performing source at the moment, In Vitro Diagnostic Reagents, Supporting Instruments and Consumables, the year earlier bringing 2.67 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought GUANGDONG HYBRIBIO 1.03 B CNY, and the year before that — 3.93 B CNY.